C P Day|O F James - JoVE Visualize

Showing results (1-10 of 240) with videos related to

Pageof 24

Sort By:

Lancet (London, England)|June 5, 1993

QT prolongation and sudden cardiac death in patients with alcoholic liver diseaseC P Day, O F James, T J Butler, et al.

Hepatology (Baltimore, Md.)|December 1, 1995

The natural history of nonalcoholic fatty liver: a follow-up studyM R Teli, O F James, A D Burt, et al.

Lancet (London, England)|October 14, 1995

Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liverM R Teli, C P Day, A D Burt, et al.

Journal of Hepatology|November 1, 1992

No evidence for involvement of type 1 collagen structural genes in 'genetic predisposition' to alcoholic cirrhosisR Bashir, C P Day, O F James, et al.

Pharmacogenetics|September 10, 1998

The RsaI polymorphism of CYP2E1 and susceptibility to alcoholic liver disease in Caucasians: effect on age of presentation and dependence on alcohol dehydrogenase genotypeJ Grove, A S Brown, A K Daly, et al.

Gut|September 1, 1995

Ranitidine increases the bioavailability of postprandial ethanol by the reduction of first pass metabolismA S Brown, J R Fiaterone, C P Day, et al.

Hepatology (Baltimore, Md.)|October 1, 1993

The activity of the metabolic form of hepatic phosphatidate phosphohydrolase correlates with the severity of alcoholic fatty liver in human beingsC P Day, O F James, A S Brown, et al.

Gut|April 6, 1999

Heterozygotes for HFE mutations have no increased risk of advanced alcoholic liver diseaseJ Grove, A K Daly, A D Burt, et al.

European Journal of Gastroenterology & Hepatology|December 10, 1997

Transjugular intrahepatic portosystemic shunt: a limited role in refractory ascitesC J Rees, J D Rose, C O Record, et al.

Clinical Science (London, England : 1979)|September 1, 1993

Plasma membrane form of phosphatidate phosphohydrolase: a possible role in signal transduction during liver fibrogenesisC P Day, A D Burt, A S Brown, et al.

Pageof 24

Showing results (1-10 of 240) with videos related to

Sort By:

Pageof 24

Lancet (London, England)|June 5, 1993

QT prolongation and sudden cardiac death in patients with alcoholic liver diseaseC P Day, O F James, T J Butler, et al.

Hepatology (Baltimore, Md.)|December 1, 1995

The natural history of nonalcoholic fatty liver: a follow-up studyM R Teli, O F James, A D Burt, et al.

Lancet (London, England)|October 14, 1995

Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liverM R Teli, C P Day, A D Burt, et al.

Journal of Hepatology|November 1, 1992

No evidence for involvement of type 1 collagen structural genes in 'genetic predisposition' to alcoholic cirrhosisR Bashir, C P Day, O F James, et al.

Pharmacogenetics|September 10, 1998

The RsaI polymorphism of CYP2E1 and susceptibility to alcoholic liver disease in Caucasians: effect on age of presentation and dependence on alcohol dehydrogenase genotypeJ Grove, A S Brown, A K Daly, et al.

Gut|September 1, 1995

Ranitidine increases the bioavailability of postprandial ethanol by the reduction of first pass metabolismA S Brown, J R Fiaterone, C P Day, et al.

Hepatology (Baltimore, Md.)|October 1, 1993

The activity of the metabolic form of hepatic phosphatidate phosphohydrolase correlates with the severity of alcoholic fatty liver in human beingsC P Day, O F James, A S Brown, et al.

Gut|April 6, 1999

Heterozygotes for HFE mutations have no increased risk of advanced alcoholic liver diseaseJ Grove, A K Daly, A D Burt, et al.

European Journal of Gastroenterology & Hepatology|December 10, 1997

Transjugular intrahepatic portosystemic shunt: a limited role in refractory ascitesC J Rees, J D Rose, C O Record, et al.

Clinical Science (London, England : 1979)|September 1, 1993

Plasma membrane form of phosphatidate phosphohydrolase: a possible role in signal transduction during liver fibrogenesisC P Day, A D Burt, A S Brown, et al.

Pageof 24